Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancer.

Stabile A, Muttin F, Zamboni S, Moschini M, Gandaglia G, Fossati N, Dell'Oglio P, Capitanio U, Cucchiara V, Mazzone E, Bravi CA, Mirone V, Montorsi F, Briganti A.

Expert Rev Anticancer Ther. 2019 Sep;19(9):739-755. doi: 10.1080/14737140.2019.1659135. Epub 2019 Aug 30.

PMID:
31469021
2.

Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer.

Martini A, Gandaglia G, Fossati N, Scuderi S, Bravi CA, Mazzone E, Stabile A, Scarcella S, Robesti D, Barletta F, Cucchiara V, Mirone V, Montorsi F, Briganti A.

Eur Urol Oncol. 2019 Apr 4. pii: S2588-9311(19)30039-2. doi: 10.1016/j.euo.2019.03.006. [Epub ahead of print]

PMID:
31411971
3.

GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 Expression.

Cucchiara V, Yang JC, Liu C, Adomat HH, Tomlinson Guns ES, Gleave ME, Gao AC, Evans CP.

Mol Cancer Ther. 2019 Oct;18(10):1811-1821. doi: 10.1158/1535-7163.MCT-18-1337. Epub 2019 Jul 24.

PMID:
31341032
4.

Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer.

Martini A, Gandaglia G, Karnes RJ, Zaffuto E, Bianchi M, Gontero P, Chlosta P, Gratzke C, Graefen M, Tilki D, Cucchiara V, Mirone V, Kneitz B, Sanchez Salas R, Van Der Poel H, Tombal B, Spahn M, Joniau TS, Montorsi F, Briganti A; European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT).

Eur Urol Oncol. 2019 Jul;2(4):456-463. doi: 10.1016/j.euo.2018.12.002. Epub 2018 Dec 24.

PMID:
31277783
5.

Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer.

Carobene A, Guerra E, Locatelli M, Cucchiara V, Briganti A, Aarsand AK, Coşkun A, Díaz-Garzón J, Fernandez-Calle P, Røraas T, Sandberg S, Jonker N, Ceriotti F; European Federation of Clinical Chemistry; Laboratory Medicine Working Group on Biological Variation.

Clin Chim Acta. 2018 Nov;486:185-191. doi: 10.1016/j.cca.2018.07.043. Epub 2018 Jul 29.

PMID:
30063887
6.

Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy.

Dell'Oglio P, Stabile A, Dias BH, Gandaglia G, Mazzone E, Fossati N, Cucchiara V, Zaffuto E, Mirone V, Suardi N, Mottrie A, Montorsi F, Briganti A.

World J Urol. 2019 Feb;37(2):221-234. doi: 10.1007/s00345-018-2360-1. Epub 2018 Jun 9. Review.

PMID:
29948044
7.

Intra versus Inter Cross-resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer.

Lombard AP, Liu L, Cucchiara V, Liu C, Armstrong CM, Zhao R, Yang JC, Lou W, Evans CP, Gao AC.

Mol Cancer Ther. 2018 Oct;17(10):2197-2205. doi: 10.1158/1535-7163.MCT-17-1269. Epub 2018 Jun 11.

8.

Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer?

Giannarini G, Fossati N, Gandaglia G, Cucchiara V, Ficarra V, Mirone V, Montorsi F, Briganti A.

Eur Urol. 2018 Aug;74(2):131-133. doi: 10.1016/j.eururo.2018.03.021. Epub 2018 Apr 4.

PMID:
29625757
9.

Genomic Markers in Prostate Cancer Decision Making.

Cucchiara V, Cooperberg MR, Dall'Era M, Lin DW, Montorsi F, Schalken JA, Evans CP.

Eur Urol. 2018 Apr;73(4):572-582. doi: 10.1016/j.eururo.2017.10.036. Epub 2017 Nov 10. Review.

PMID:
29129398
10.

Human Prostate Tissue-derived Extracellular Matrix as a Model of Prostate Microenvironment.

Cazzaniga W, Nebuloni M, Longhi E, Locatelli I, Allevi R, Lucianò R, Senatore G, Ventimiglia E, Cucchiara V, Genovese L, Montorsi F, Alfano M, Salonia A, Cavarretta I.

Eur Urol Focus. 2016 Oct;2(4):400-408. doi: 10.1016/j.euf.2016.02.016. Epub 2016 Mar 10.

PMID:
28723472
11.

ABCB1 Mediates Cabazitaxel-Docetaxel Cross-Resistance in Advanced Prostate Cancer.

Lombard AP, Liu C, Armstrong CM, Cucchiara V, Gu X, Lou W, Evans CP, Gao AC.

Mol Cancer Ther. 2017 Oct;16(10):2257-2266. doi: 10.1158/1535-7163.MCT-17-0179. Epub 2017 Jul 11.

12.

Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer.

Liu C, Armstrong CM, Lou W, Lombard AP, Cucchiara V, Gu X, Yang JC, Nadiminty N, Pan CX, Evans CP, Gao AC.

Mol Cancer Ther. 2017 Aug;16(8):1521-1530. doi: 10.1158/1535-7163.MCT-16-0912. Epub 2017 May 12.

13.

Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.

Cucchiara V, Yang JC, Mirone V, Gao AC, Rosenfeld MG, Evans CP.

Cancers (Basel). 2017 Jan 16;9(1). pii: E9. doi: 10.3390/cancers9010009. Review.

14.

The impact of previous prostate surgery on the outcomes of laparoscopic radical prostatectomy.

Verze P, Greco F, Scuzzarella S, Bottone F, Palmieri A, Cucchiara V, Arcaniolo D, Imperatore V, Creta M, Mirone V.

Minerva Urol Nefrol. 2017 Feb;69(1):76-84. doi: 10.23736/S0393-2249.16.02612-6. Epub 2016 Jun 29.

PMID:
28009148
15.

Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely?

Fossati N, Rossi MS, Cucchiara V, Gandaglia G, Dell'Oglio P, Moschini M, Suardi N, Dehò F, Montorsi F, Schiavina R, Mottrie A, Briganti A.

Urol Oncol. 2017 Apr;35(4):150.e9-150.e15. doi: 10.1016/j.urolonc.2016.11.010. Epub 2016 Dec 13.

PMID:
27986374
16.

The role of prostatic inflammation in the development and progression of benign and malignant diseases.

Gandaglia G, Zaffuto E, Fossati N, Cucchiara V, Mirone V, Montorsi F, Briganti A.

Curr Opin Urol. 2017 Mar;27(2):99-106. doi: 10.1097/MOU.0000000000000369. Review.

PMID:
27906778
17.

Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches.

Bianchi L, Gandaglia G, Fossati N, Suardi N, Moschini M, Cucchiara V, Bianchi M, Damiano R, Schiavina R, Shariat SF, Montorsi F, Briganti A.

Urologia. 2017 Feb 3;84(1):9-19. doi: 10.5301/uro.5000139. Epub 2015 Dec 16. Review.

PMID:
26689534
18.

The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two-Center Validation Study.

Dell'Oglio P, Karnes RJ, Gandaglia G, Fossati N, Stabile A, Moschini M, Cucchiara V, Zaffuto E, Karakiewicz PI, Suardi N, Montorsi F, Briganti A.

Prostate. 2017 Feb;77(3):263-273. doi: 10.1002/pros.23265. Epub 2016 Oct 18.

PMID:
27753114
19.

Early Postoperative Radiotherapy is Associated with Worse Functional Outcomes in Patients with Prostate Cancer.

Zaffuto E, Gandaglia G, Fossati N, Dell'Oglio P, Moschini M, Cucchiara V, Suardi N, Mirone V, Bandini M, Shariat SF, Karakiewicz PI, Montorsi F, Briganti A.

J Urol. 2017 Mar;197(3 Pt 1):669-675. doi: 10.1016/j.juro.2016.09.079. Epub 2016 Sep 23.

PMID:
27670915
20.

Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years.

Moschini M, Luzzago S, Cazzaniga W, Cucchiara V, Bandini M, Damiano R, Soria F, Klatte T, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

Clin Genitourin Cancer. 2017 Apr;15(2):e223-e228. doi: 10.1016/j.clgc.2016.07.024. Epub 2016 Aug 8.

PMID:
27589904
21.

Incidence and Predictors of 30-Day Readmission After Robot-Assisted Radical Prostatectomy.

Moschini M, Gandaglia G, Fossati N, Dell'Oglio P, Cucchiara V, Luzzago S, Zaffuto E, Suardi N, Damiano R, Shariat SF, Montorsi F, Briganti A.

Clin Genitourin Cancer. 2017 Feb;15(1):67-71. doi: 10.1016/j.clgc.2016.06.002. Epub 2016 Jun 29.

PMID:
27452733
22.

Rationale for local treatment in the management of metastatic prostate cancer.

Gandaglia G, Fossati N, Dell'Oglio P, Moschini M, Cucchiara V, Suardi N, Mottrie A, Mirone V, Montorsi F, Briganti A.

Curr Opin Support Palliat Care. 2016 Sep;10(3):266-72. doi: 10.1097/SPC.0000000000000218. Review.

PMID:
27328411
23.

Perioperative and renal functional outcomes of laparoscopic partial nephrectomy (LPN) for renal tumours of high surgical complexity: a single-institute comparison between clampless and clamped procedures.

Verze P, Fedelini P, Chiancone F, Cucchiara V, La Rocca R, Fedelini M, Meccariello C, Palmieri A, Mirone V.

World J Urol. 2017 Mar;35(3):403-409. doi: 10.1007/s00345-016-1882-7. Epub 2016 Jun 20.

PMID:
27324881
24.

The Impact of Perioperative Blood Transfusion on Survival of Bladder Cancer Patients Submitted to Radical Cystectomy: Role of Anemia Status.

Moschini M, Bianchi M, Gandaglia G, Cucchiara V, Luzzago S, Pellucchi F, Damiano R, Serretta V, Briganti A, Montorsi F, Salonia A, Colombo R.

Eur Urol Focus. 2016 Apr;2(1):86-91. doi: 10.1016/j.euf.2015.03.002. Epub 2015 Jun 3.

PMID:
28723456
25.

Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.

Moschini M, Karnes RJ, Sharma V, Gandaglia G, Fossati N, Dell'Oglio P, Cucchiara V, Capogrosso P, Shariat SF, Damiano R, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.

Eur J Surg Oncol. 2016 May;42(5):735-43. doi: 10.1016/j.ejso.2016.02.011. Epub 2016 Feb 18.

PMID:
26927300
26.

Penile rehabilitation after radical prostatectomy: does it work?

Gandaglia G, Suardi N, Cucchiara V, Bianchi M, Shariat SF, Roupret M, Salonia A, Montorsi F, Briganti A.

Transl Androl Urol. 2015 Apr;4(2):110-23. doi: 10.3978/j.issn.2223-4683.2015.02.01. Review.

27.

Comparison of Treatment Emergent Adverse Events in Men With Premature Ejaculation Treated With Dapoxetine and Alternate Oral Treatments: Results From a Large Multinational Observational Trial.

Verze P, Cai T, Magno C, Sabella F, Cucchiara V, Palmieri A, Mirone V.

J Sex Med. 2016 Feb;13(2):194-9. doi: 10.1016/j.jsxm.2015.12.017. Epub 2016 Jan 21.

PMID:
26805941
28.

Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience.

Moschini M, Gandaglia G, Dell'Oglio P, Fossati N, Cucchiara V, Burgio G, Mattei A, Damiano R, Shariat SF, Salonia A, Montorsi F, Briganti A, Colombo R, Gallina A.

Clin Genitourin Cancer. 2016 Aug;14(4):e341-6. doi: 10.1016/j.clgc.2015.12.017. Epub 2015 Dec 23.

PMID:
26797584
29.

Determinants of long-term survival of patients with locally advanced prostate cancer: the role of extensive pelvic lymph node dissection.

Moschini M, Fossati N, Abdollah F, Gandaglia G, Cucchiara V, Dell'Oglio P, Luzzago S, Shariat SF, Dehò F, Salonia A, Montorsi F, Briganti A.

Prostate Cancer Prostatic Dis. 2016 Mar;19(1):63-7. doi: 10.1038/pcan.2015.51. Epub 2015 Nov 10.

PMID:
26553644
30.

Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution.

Moschini M, Dell' Oglio P, Capogrosso P, Cucchiara V, Luzzago S, Gandaglia G, Zattoni F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R.

Clin Genitourin Cancer. 2015 Dec;13(6):562-7. doi: 10.1016/j.clgc.2015.04.009. Epub 2015 May 4.

PMID:
26004301
31.

Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival.

Nini A, Gandaglia G, Fossati N, Suardi N, Cucchiara V, Dell'Oglio P, Cazzaniga W, Luzzago S, Montorsi F, Briganti A.

Eur Urol. 2015 Nov;68(5):777-84. doi: 10.1016/j.eururo.2015.04.035. Epub 2015 May 8.

PMID:
25959166
32.

Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy.

Moschini M, Sharma V, Dell'oglio P, Cucchiara V, Gandaglia G, Cantiello F, Zattoni F, Pellucchi F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R.

BJU Int. 2016 Apr;117(4):604-10. doi: 10.1111/bju.13146. Epub 2015 Jun 3.

33.

Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer.

Moschini M, Gandaglia G, Suardi N, Fossati N, Cucchiara V, Damiano R, Cantiello F, Shariat SF, Montorsi F, Briganti A.

Int J Urol. 2015 Jun;22(6):555-61. doi: 10.1111/iju.12748. Epub 2015 Mar 17.

34.

A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy.

Gallina A, Bianchi M, Gandaglia G, Cucchiara V, Suardi N, Montorsi F, Briganti A.

Eur Urol. 2015 Nov;68(5):750-3. doi: 10.1016/j.eururo.2015.02.002. Epub 2015 Feb 17.

PMID:
25700565
35.

How to optimize patient selection for robot-assisted radical prostatectomy: functional outcome analyses from a tertiary referral center.

Gandaglia G, Suardi N, Gallina A, Zaffuto E, Cucchiara V, Vizziello D, Shariat S, Cantiello F, Damiano R, Guazzoni G, Montorsi F, Briganti A.

J Endourol. 2014 Jul;28(7):792-800. doi: 10.1089/end.2014.0007. Epub 2014 Mar 24.

PMID:
24660774
36.

Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.

Suardi N, Gandaglia G, Gallina A, Di Trapani E, Scattoni V, Vizziello D, Cucchiara V, Bertini R, Colombo R, Picchio M, Giovacchini G, Montorsi F, Briganti A.

Eur Urol. 2015 Feb;67(2):299-309. doi: 10.1016/j.eururo.2014.02.011. Epub 2014 Feb 18.

PMID:
24571959
37.

External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.

Dell'Oglio P, Abdollah F, Suardi N, Gallina A, Cucchiara V, Vizziello D, Zaffuto E, Cantiello F, Damiano R, Shariat S, Montorsi F, Briganti A.

J Endourol. 2014 Apr;28(4):416-23. doi: 10.1089/end.2013.0571. Epub 2014 Jan 9.

PMID:
24188052
38.

Breast augmentation: Part III--preoperative considerations and planning.

Berry MG, Cucchiara V, Davies DM.

J Plast Reconstr Aesthet Surg. 2011 Nov;64(11):1401-9. doi: 10.1016/j.bjps.2011.03.028. Epub 2011 Apr 27. Review.

PMID:
21524951
39.

Breast augmentation: Part II--Adverse capsular contracture.

Berry MG, Cucchiara V, Davies DM.

J Plast Reconstr Aesthet Surg. 2010 Dec;63(12):2098-107. doi: 10.1016/j.bjps.2010.04.011. Epub 2010 Jun 25. Review.

PMID:
20579948
40.

A rare case of giant cutaneous horn.

Tillo O, Chin KF, Vidya R, Cucchiara V, Sterne GD.

Acta Chir Plast. 2010;52(2-4):57-9.

PMID:
21749012
41.

The intrinsic neuroadipofascial pedicled fasciocutaneous flap.

Ross GL, Cucchiara V, Oudit D, Berry MG, Howcroft A.

Br J Plast Surg. 2005 Jun;58(4):577-9. No abstract available.

PMID:
15897048
42.

An idea for umbilicus reconstruction.

Abenavoli FM, Cusano V, Cucchiara V, D'Amico C, Corvelli L.

Ann Plast Surg. 2001 Feb;46(2):194. No abstract available.

PMID:
11216626
43.

Controversial issues in diagnosis of liposarcomas of the thigh. A report of 18 cases.

Ribuffo D, Onesti MG, Elia E, Cucchiara V, Valeriani M, Scuderi N.

Scand J Plast Reconstr Surg Hand Surg. 1998 Sep;32(3):323-30.

PMID:
9785438

Supplemental Content

Loading ...
Support Center